A share price of Fulgent Genetics Inc [FLGT] is currently trading at $27.16, up 3.03%. An important factor to consider is whether the stock is rising or falling in short-term value. The FLGT shares have gain 17.52% over the last week, with a monthly amount glided 20.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fulgent Genetics Inc [NASDAQ: FLGT] stock has seen the most recent analyst activity on August 05, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $30 for it. Previously, UBS started tracking the stock with Neutral rating on December 07, 2023, and set its price target to $35. On December 08, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $40 on the stock. Raymond James started tracking the stock assigning a Outperform rating and suggested a price target of $45 on November 18, 2022. Credit Suisse initiated its recommendation with a Outperform and recommended $65 as its price target on August 25, 2022.
Fulgent Genetics Inc experienced fluctuations in its stock price throughout the past year between $14.57 and $27.36. Currently, Wall Street analysts expect the stock to reach $25.5 within the next 12 months. Fulgent Genetics Inc [NASDAQ: FLGT] shares were valued at $27.16 at the most recent close of the market. An investor can expect a potential drop of -6.11% based on the average FLGT price forecast.
Analyzing the FLGT fundamentals
Trailing Twelve Months sales for Fulgent Genetics Inc [NASDAQ:FLGT] were 315.55M which represents 17.18% growth. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.15%, and Net Profit Margin reading is -0.14%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.04 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.47 points at the first support level, and at 25.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.01, and for the 2nd resistance point, it is at 28.85.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fulgent Genetics Inc [NASDAQ:FLGT] is 7.01. On the other hand, the Quick Ratio is 7.01, and the Cash Ratio is 1.62. Considering the valuation of this stock, the price to sales ratio is 2.63, the price to book ratio is 0.74.
Transactions by insiders
Recent insider trading involved Gao Hanlin, Chief Scientific Officer, that happened on Sep 03 ’25 when 1063.0 shares were sold. President and COO, Xie Jian completed a deal on Sep 03 ’25 to sell 1128.0 shares. Meanwhile, Officer Xie Jian bought 1128.0 shares on Sep 03 ’25.
